Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
종목 코드 PRE
회사 이름Prenetics Global Ltd
상장일Jul 06, 2021
CEOMr. Joel Neoh
직원 수285
유형Ordinary Share
회계 연도 종료Jul 06
주소Unit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
도시
증권 거래소London Stock Exchange
국가Hong Kong
우편 번호- -
전화85222109588
웹사이트https://ir.prenetics.com/
종목 코드 PRE
상장일Jul 06, 2021
CEOMr. Joel Neoh
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음